Treatment of primary XXXX .

@entity1 @entity632 @entity706 @entity1074 @entity229 @entity25221 @entity262 @entity786 @entity3003 @entity2879 @entity1892 @entity1891 @entity1260 @entity1893 @entity8057 @entity19166
We present an overview of the treatment and clinical outcome of 15 @entity19166 , carried out in our center from 1993 to 2002. The surgical approach was determined by the location, and type of the lesion. Lateral orbitotomy was performed in five laterally located lesions, a transconjunctival approach in five medial, basal, extra-, intraconal lesions. Pterional intradural and extradural and intradural approaches (three) were used in case of intracranial involvement or location in the apex and optic canal. Two lesions of the lid or extraconal space were operated via @entity25221 . Ten @entity1 were diagnosed as extranodal @entity1074 . Diffuse large @entity1892 (DLCL) was encountered in two @entity1 , @entity706 ( @entity706 ) in two @entity1 , and diffuse lymphoplasmacytic/ @entity8057 in one @entity1 . All @entity1 except one failed to reveal @entity262 and had a localized @entity19166 . Twelve of the @entity1 responded to radiation therapy with usually 40 Gy. @entity786 , @entity632 , @entity1891 , @entity229 chemotherapy was applied in two @entity1 , once in combination with radiotherapy. Local recurrence was seen in one @entity1 with @entity706 . Systemic manifestation occurred in one @entity1 with DLCL, undergoing @entity1260 , @entity3003 , @entity2879 chemotherapy with complete remission. The course of orbital @entity1893 is variable and requires a multidisciplinary treatment. Therapeutic options include surgical biopsy, radiation therapy, and chemotherapy.
